Expressed HCV NS5B possesses primer-dependent RNA polymerase activity.

被引：0
|
作者：
Chung, RT [1 ]
Kawashima, T [1 ]
Kaplan, LM [1 ]
机构：
[1] MASSACHUSETTS GEN HOSP, GASTROINTESTINAL UNIT, BOSTON, MA 02114 USA
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1172 / A1172
页数：1
相关论文
共 50 条
  • [41] Updateon different aspects of HCV variability: focus on NS5B polymerase
    Nadia Marascio
    Carlo Torti
    Maria Carla Liberto
    Alfredo Focà
    BMC Infectious Diseases, 14
  • [42] Update on different aspects of HCV variability: focus on NS5B polymerase
    Marascio, Nadia
    Torti, Carlo
    Liberto, Maria Carla
    Foca, Alfredo
    BMC INFECTIOUS DISEASES, 2014, 14
  • [43] The First Kilogram Synthesis of Beclabuvir, an HCV NS5B Polymerase Inhibitor
    Bien, Jeffrey
    Davulcu, Akin
    DelMonte, Albert J.
    Fraunhoffer, Kenneth J.
    Gao, Zhinong
    Hang, Chao
    Hsiao, Yi
    Hu, Wenhao
    Katipally, Kishta
    Littke, Adam
    Pedro, Aghogho
    Qiu, Yuping
    Sandoval, Maria
    Schild, Richard
    Soltani, Michelle
    Tedesco, Anthony
    Vanyo, Dale
    Vemishetti, Purushotham
    Waltermire, Robert E.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2018, 22 (10) : 1393 - 1408
  • [44] Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus
    Lohmann, V
    Roos, A
    Körner, F
    Koch, JO
    Bartenschlager, R
    VIROLOGY, 1998, 249 (01) : 108 - 118
  • [45] Aryl 1-uracil inhibitors of HCV genotype 1 NS5B RNA-dependent RNA polymerase: Uracil ring replacements
    Pratt, John K.
    Betebenner, David
    Flentge, Charles
    Liu, Dachun
    Rockway, Todd
    Wagner, Rolf
    Maring, Clarence
    Liu, Yaya
    Koev, Gennadiey
    Ben Lim, Hock
    Beyer, Jill
    Mondal, Rubina
    Barnes, David
    Kotecki, Brian
    Beno, David
    Marsh, Kennan
    Longenecker, Kenton
    Kati, Warren
    Kempf, Dale
    Molla, Akhteruzzaman
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [46] Characterization of recombinant hepatitis C virus NS5B protein (RNA-dependent RNA polymerase).
    Al, RH
    Xie, Y
    Wang, Y
    DeStaercke, CM
    Hagedorn, CH
    HEPATOLOGY, 1997, 26 (04) : 513 - 513
  • [47] MEDI 268-Allosteric non-nucleoside inhibitors of HCV RNA polymerase (NS5B)
    Burns, Christopher J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 232
  • [48] Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus
    Lohmann, V
    Roos, A
    Körner, F
    Koch, JO
    Bartenschlager, R
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (03) : 167 - 174
  • [49] The hepatitis C virus NS5B RNA-dependent RNA polymerase activity and susceptibility to inhibitors is modulated by metal cations
    Alaoui-Ismaili, MH
    Hamel, M
    L'Heureux, L
    Nicolas, O
    Bilimoria, D
    Labonté, P
    Mounir, S
    Rando, RF
    JOURNAL OF HUMAN VIROLOGY, 2000, 3 (06) : 306 - 316
  • [50] Genetic and biochemical diversity in the HCV NS5B RNA polymerase in the context of interferon α plus ribavirin therapy
    Cao, F.
    Donlin, M. J.
    Turner, K.
    Cheng, X.
    Tavis, J. E.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (05) : 349 - 357
12345